IPP Bureau

Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania
Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania

By IPP Bureau - May 27, 2022

The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential

Augnito introduces key update to its Voice AI solution
Augnito introduces key update to its Voice AI solution

By IPP Bureau - May 26, 2022

The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model

TN govt. hospital performs robotic-assisted surgery
TN govt. hospital performs robotic-assisted surgery

By IPP Bureau - May 26, 2022

The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year

Daman collaborates with Janssen to develop digital health tool
Daman collaborates with Janssen to develop digital health tool

By IPP Bureau - May 26, 2022

The aim is to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)

Roche develops unique PCR tests to detect monkeypox virus
Roche develops unique PCR tests to detect monkeypox virus

By IPP Bureau - May 26, 2022

Roche and its subsidiary TIB Molbiol have developed three different LightMix Modular Virus kits for the detection of the virus

Excelra Partners with HotSpot Therapeutics to enhance allosteric drug discovery efforts
Excelra Partners with HotSpot Therapeutics to enhance allosteric drug discovery efforts

By IPP Bureau - May 26, 2022

The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities
Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities

By IPP Bureau - May 26, 2022

ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E

Honeywell and Narayana Health partner to explore co-creation of healthcare technologies
Honeywell and Narayana Health partner to explore co-creation of healthcare technologies

By IPP Bureau - May 26, 2022

Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies

Lumenis OptiLight wins 2022 MedTech Breakthrough Award
Lumenis OptiLight wins 2022 MedTech Breakthrough Award

By IPP Bureau - May 26, 2022

For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies

ASG Eye Hospitals opens unit in Dombivli, Maharashtra
ASG Eye Hospitals opens unit in Dombivli, Maharashtra

By IPP Bureau - May 26, 2022

The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra

Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr
Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr

By IPP Bureau - May 26, 2022

The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.

Pristyn Care announces ‘CARES’ initiative
Pristyn Care announces ‘CARES’ initiative

By IPP Bureau - May 26, 2022

Five patient-first principles to provide the highest standard of healthcare

Eugia Pharma receives USFDA approval for Pemetrexed
Eugia Pharma receives USFDA approval for Pemetrexed

By IPP Bureau - May 26, 2022

Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)

Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection
Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection

By IPP Bureau - May 26, 2022

Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)

Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market
Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market

By IPP Bureau - May 25, 2022

The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA

Latest Stories

Interviews

Packaging